# | Aladdin ID | Assay Type | Description | Organism | Compounds | Reference | BAO Format | Source | |
---|---|---|---|---|---|---|---|---|---|
1. | ALA658407 | Functional | Compound was evaluated against Human cell line CNS SF-295 | Homo sapiens | 3 | ALA1132710 | cell-based format | Scientific Literature | |
2. | ALA658408 | Functional | Cytotoxicity against CNS SF-295 cell lines | Homo sapiens | 5 | ALA1134690 | cell-based format | Scientific Literature | |
3. | ALA658409 | Functional | In vitro cytotoxicity against CNS SF-295 human tumors following a 2 day exposure. | Homo sapiens | 8 | ALA1131966 | cell-based format | Scientific Literature | |
4. | ALA858300 | Functional | Cytotoxicity against human CNS SF-295 cell line | Homo sapiens | 4 | ALA1149098 | cell-based format | Scientific Literature | |
5. | ALA658410 | Functional | Tested for cytostatic activity against Central nervous system SF-295 cell line of NCI 60 tumor cell line panel | Homo sapiens | 4 | ALA1133918 | cell-based format | Scientific Literature | |
6. | ALA658128 | Functional | In vitro growth inhibition against CNS cancer SF-295 cell line was reported. | Homo sapiens | 3 | ALA1135808 | cell-based format | Scientific Literature | |
7. | ALA658129 | Functional | Log of molar concentration leading to 50% cell death against CNS cancer SF-295 cell line was reported | Homo sapiens | 3 | ALA1135808 | cell-based format | Scientific Literature | |
8. | ALA658130 | Functional | In vitro total growth inhibition against CNS cancer SF-295 cell lines was reported. | Homo sapiens | 3 | ALA1135808 | cell-based format | Scientific Literature | |
9. | ALA654307 | Functional | Compound was tested in vitro for its antitumor activity against CNS cancer cell line SF-295 (50% growth inhibition of tumor cells after 48 hr exposure ) | Homo sapiens | 3 | ALA1132884 | cell-based format | Scientific Literature | |
10. | ALA883904 | Functional | Evaluated for growth inhibition (anticancer activity) in Human CNS cancer SF-295 cell line | Homo sapiens | 1 | ALA1133024 | cell-based format | Scientific Literature | |
11. | ALA696912 | Functional | Evaluated for growth inhibition (anticancer activity) of Human CNS cancer SF-295 cell line | Homo sapiens | 7 | ALA1133024 | cell-based format | Scientific Literature | |
12. | ALA1287580 | Functional | Cytotoxicity against human SF295 cells at 5 ug/ml after 72 hrs by MTT assay | Homo sapiens | 5 | ALA1275359 | cell-based format | Scientific Literature | |
13. | ALA1292614 | Functional | Antitumor activity against human SF295 cells at 10 uM after 48 hrs by sulforhodamine B assay relative to control | Homo sapiens | 5 | ALA1287652 | cell-based format | Scientific Literature | |
14. | ALA1292664 | Functional | Growth inhibition of human SF295 cells after 48 hrs by sulforhodamine B assay | Homo sapiens | 3 | ALA1287802 | cell-based format | Scientific Literature | |
15. | ALA1292753 | Functional | Antitumor activity against human SF295 cells after 48 hrs by sulforhodamine B assay | Homo sapiens | 2 | ALA1287652 | cell-based format | Scientific Literature | |
16. | ALA1292888 | Functional | Growth inhibition of human SF295 cells after 48 hrs by sulforhodamine B assay | Homo sapiens | 5 | ALA1287654 | cell-based format | Scientific Literature | |
17. | ALA1292237 | Functional | Anticancer activity against human SF295 cells | Homo sapiens | 3 | ALA1287680 | cell-based format | Scientific Literature | |
18. | ALA1062464 | Functional | Growth inhibition of human SF295 cells assessed as drug level required for 50% reduction in net protein increase by SRB assay relative to control | Homo sapiens | 5 | ALA1153480 | cell-based format | Scientific Literature | |
19. | ALA1060677 | Functional | Cytotoxicity against human SF295 cells by SRB assay | Homo sapiens | 5 | ALA1153480 | cell-based format | Scientific Literature | |
20. | ALA1062449 | Functional | Growth inhibition of human SF295 cells assessed as cell growth at 10 uM by SRB assay | Homo sapiens | 7 | ALA1153480 | cell-based format | Scientific Literature |